_id

690db2ecccc777a4e85d0ca7

Ticker

ATXI

Name

Avenue Therapeutics Inc

Exchange

PINK

Address

1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.avenuetx.com

Description

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Last Close

0.6503

Volume

751

Current Price

0.6503

Change

0

Last Updated

2025-11-28T12:32:27.195Z

Image

-

Ipo Date

2017-06-27T00:00:00.000Z

Market Cap

2766193

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9977

Sentiment Sources

3

Rating

4

Target Price

8

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

724000

Operating Income

-724000

Interest Expense

-

Pretax Income

-683000

Net Income

-683000

Eps

-0.21453983247674457

Dividends Per Share

-

Shares Outstanding

3183558

Income Tax Expense

-

EBITDA

-683000

Operating Margin

-

Total Other Income Expense Net

41000

Cash

3709000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

3709000

Property Plant Equipment

-

Total Assets

3725000

Payables

490000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

1422000

Equity

3557000

Depreciation

-

Change In Working Capital

910000

Cash From Operations

383000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

0

Net Change In Cash

383000

PE

1.1284

PB

0.5820263613719426

ROE

-19.201574360416082

ROA

-18.335570469798657

FCF

383000

Fcf Percent

-

Piotroski FScore

2

Health Score

43

Deep Value Investing Score

10

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

5.8

Garp Investing Score

4

Growth Investing Score

3

Momentum Investing Score

2.5

Net Net Investing Score

6.5

Quality Investing Score

4.5

Value Investing Score

9.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

724000

Quarters > 0 > income Statement > operating Income

-724000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-683000

Quarters > 0 > income Statement > net Income

-683000

Quarters > 0 > income Statement > eps

-0.21453983247674457

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

3183558

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-683000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

41000

Quarters > 0 > balance Sheet > cash

3709000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

3709000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

3725000

Quarters > 0 > balance Sheet > payables

490000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1422000

Quarters > 0 > balance Sheet > equity

3557000

Quarters > 0 > cash Flow > net Income

-698000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

910000

Quarters > 0 > cash Flow > cash From Operations

383000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

383000

Quarters > 0 > ratios > PE

-0.21453983247674457

Quarters > 0 > ratios > PB

0.5820263613719426

Quarters > 0 > ratios > ROE

-19.201574360416082

Quarters > 0 > ratios > ROA

-18.335570469798657

Quarters > 0 > ratios > FCF

383000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1404000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

1404000

Quarters > 1 > income Statement > operating Expenses

1107000

Quarters > 1 > income Statement > operating Income

297000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

329000

Quarters > 1 > income Statement > net Income

335000

Quarters > 1 > income Statement > eps

0.10522817551934031

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

3183558

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

297000

Quarters > 1 > income Statement > operating Margin

21.153846153846153

Quarters > 1 > income Statement > total Other Income Expense Net

32000

Quarters > 1 > balance Sheet > cash

3326000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

800000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

4161000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

4161000

Quarters > 1 > balance Sheet > payables

79000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1329000

Quarters > 1 > balance Sheet > equity

4058000

Quarters > 1 > cash Flow > net Income

329000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-675000

Quarters > 1 > cash Flow > cash From Operations

-176000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-176000

Quarters > 1 > ratios > PE

0.10522817551934031

Quarters > 1 > ratios > PB

0.5101694843272547

Quarters > 1 > ratios > ROE

8.255298176441597

Quarters > 1 > ratios > ROA

8.050949291035808

Quarters > 1 > ratios > FCF

-176000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

-0.12535612535612536

Quarters > 1 > health Score

62

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

1905000

Quarters > 2 > income Statement > operating Income

-1905000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-1858000

Quarters > 2 > income Statement > net Income

-1852000

Quarters > 2 > income Statement > eps

-0.6233591383372602

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

2971000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1905000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

47000

Quarters > 2 > balance Sheet > cash

3502000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

3594000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

3594000

Quarters > 2 > balance Sheet > payables

173000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1262000

Quarters > 2 > balance Sheet > equity

3510000

Quarters > 2 > cash Flow > net Income

-1858000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

447000

Quarters > 2 > cash Flow > cash From Operations

-1186000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

2094000

Quarters > 2 > cash Flow > net Change In Cash

908000

Quarters > 2 > ratios > PE

-0.6233591383372602

Quarters > 2 > ratios > PB

0.5504391168091168

Quarters > 2 > ratios > ROE

-52.76353276353276

Quarters > 2 > ratios > ROA

-51.53032832498609

Quarters > 2 > ratios > FCF

-1186000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

1596000

Quarters > 3 > income Statement > operating Income

-1596000

Quarters > 3 > income Statement > interest Expense

0

Quarters > 3 > income Statement > pretax Income

-1559000

Quarters > 3 > income Statement > net Income

-1544000

Quarters > 3 > income Statement > eps

-0.965

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1600000

Quarters > 3 > income Statement > income Tax Expense

-9000

Quarters > 3 > income Statement > EBITDA

-1559000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

37000

Quarters > 3 > balance Sheet > cash

2594000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2672000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

2672000

Quarters > 3 > balance Sheet > payables

155000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

816000

Quarters > 3 > balance Sheet > equity

2797000

Quarters > 3 > cash Flow > net Income

-1559000

Quarters > 3 > cash Flow > depreciation

-3899000

Quarters > 3 > cash Flow > change In Working Capital

-194000

Quarters > 3 > cash Flow > cash From Operations

-764000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

761000

Quarters > 3 > cash Flow > net Change In Cash

-3000

Quarters > 3 > ratios > PE

-0.965

Quarters > 3 > ratios > PB

0.37199856989631747

Quarters > 3 > ratios > ROE

-55.202002145155525

Quarters > 3 > ratios > ROA

-57.784431137724546

Quarters > 3 > ratios > FCF

-764000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

42

Valuation > metrics > PE

1.1284

Valuation > metrics > PB

0.5820263613719426

Valuation > final Score

90

Valuation > verdict

65.3% Undervalued

Profitability > metrics > ROE

-19.201574360416082

Profitability > metrics > ROA

-18.4146670261526

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3997750913691313

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

7.569387755102041

Liquidity > metrics > Quick Ratio

7.569387755102041

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

90

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

71

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

97

Prev Risks > 1

-102

Prev Risks > 2

80

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:15:08.439Z